Pure Global

Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use - Trial NCT05166902

Access comprehensive clinical trial information for NCT05166902 through Pure Global AI's free database. This phase not specified trial is sponsored by Coopervision, Inc. and is currently Completed. The study focuses on Ametropia. Target enrollment is 67 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT05166902
Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT05166902
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Evaluation of Monthly Replacement Lenses in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use
Evaluation of Monthly Replacement Lens Designs in Habitual Soft Contact Lens Wearers Who Report Frequent Digital Devise Use

Study Focus

Ametropia

Lens A (comfilcon A lens)

Interventional

device

Sponsor & Location

Coopervision, Inc.

Ocoee,State College,Toronto,Toronto, Canada,United States of America

Timeline & Enrollment

N/A

Jan 31, 2022

Jul 09, 2022

67 participants

Primary Outcome

Subjective Ratings on Lens Handling on Removal

Summary

To evaluate the clinical performance of two monthly silicone hydrogel contact lenses in
 habitual wearers of frequent replacement (FRP) lenses when worn for 1-month.

ICD-10 Classifications

Amblyopia ex anopsia
Amoebiasis
Amoebiasis, unspecified
Myoclonus
Oesophagitis

Data Source

ClinicalTrials.gov

NCT05166902

Device Trial